Please use this identifier to cite or link to this item: https://doi.org/10.3389/fphar.2020.00831
DC FieldValue
dc.titleStructural Dependence of Sulfated Polysaccharide for Diabetes Management: Fucoidan From Undaria pinnatifida Inhibiting α-Glucosidase More Strongly Than α-Amylase and Amyloglucosidase
dc.contributor.authorKoh, H.S.A.
dc.contributor.authorLu, J.
dc.contributor.authorZhou, W.
dc.date.accessioned2021-08-23T03:26:22Z
dc.date.available2021-08-23T03:26:22Z
dc.date.issued2020-06-05
dc.identifier.citationKoh, H.S.A., Lu, J., Zhou, W. (2020-06-05). Structural Dependence of Sulfated Polysaccharide for Diabetes Management: Fucoidan From Undaria pinnatifida Inhibiting α-Glucosidase More Strongly Than α-Amylase and Amyloglucosidase. Frontiers in Pharmacology 11 : 831. ScholarBank@NUS Repository. https://doi.org/10.3389/fphar.2020.00831
dc.identifier.issn16639812
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/198788
dc.description.abstractFucoidan refers to a group of sulfated polysaccharide that is commonly obtained from various species of brown seaweed. Fucoidan has gained increased popularity among researchers in the recent years due to its numerous biological activities, including its inhibitory effects against starch hydrolyzing enzymes such as α-amylase and α-glucosidase. This highlights the potential of fucoidan as an antidiabetic agent in the management and prevention of diabetes mellitus. In this study, the inhibitory effects of fucoidan isolated from the New Zealand Undaria pinnatifida seaweed species against three starch hydrolyzing enzymes—α-amylase, α-glucosidase, and amyloglucosidase—was investigated. It was demonstrated that while the fucoidan exhibited significant inhibitory effects against all the three starch hydrolases, it is an uncompetitive inhibitor of α-amylase and amyloglucosidase, and is a competitive inhibitor of α-glucosidase. Moreover, it exhibited significantly stronger inhibitory effects against α-glucosidase than α-amylase, thus having the desirable characteristics as an antidiabetic agent. © Copyright © 2020 Koh, Lu and Zhou.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2020
dc.subjectamyloglucosidase
dc.subjectDiabetes
dc.subjectfucoidan
dc.subjectUndaria pinnatifida
dc.subjectα-amylase
dc.subjectα-glucosidase
dc.typeArticle
dc.contributor.departmentFOOD SCIENCE & TECHNOLOGY
dc.description.doi10.3389/fphar.2020.00831
dc.description.sourcetitleFrontiers in Pharmacology
dc.description.volume11
dc.description.page831
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fphar_2020_00831.pdf780.86 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons